Study of Tamoxifen and Raloxifene
From Wikipedia, the free encyclopedia
The Study of Tamoxifen and Raloxifene (STAR) is a clinical trial from the early 2000s designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in women who are at increased risk of the disease.[1]
This article needs more reliable medical references for verification or relies too heavily on primary sources. (February 2022) |